Targeting mTOR in RET mutant medullary and differentiated thyroid cancer cells
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting mTOR in RET mutant medullary and differentiated thyroid cancer cells
Authors
Keywords
-
Journal
ENDOCRINE-RELATED CANCER
Volume 20, Issue 5, Pages 659-667
Publisher
Bioscientifica
Online
2013-07-05
DOI
10.1530/erc-13-0085
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Misidentification of Putative Medullary Thyroid Cancer Cell Lines RO-H85-1 and RO-D81-1
- (2013) Tikva Dadon et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Novel withanolides target medullary thyroid cancer through inhibition of both RET phosphorylation and the mammalian target of rapamycin pathway
- (2012) Abbas K. Samadi et al. SURGERY
- Targeting the PI3K/mTOR Pathway in Murine Endocrine Cell Lines
- (2011) Christophe Couderc et al. AMERICAN JOURNAL OF PATHOLOGY
- Defining the role of TORC1/2 in multiple myeloma
- (2011) P. Maiso et al. BLOOD
- Synergistic Action of a RAF Inhibitor and a Dual PI3K/mTOR Inhibitor in Thyroid Cancer
- (2011) N. Jin et al. CLINICAL CANCER RESEARCH
- Sorafenib and Mek inhibition is synergistic in medullary thyroid carcinoma in vitro
- (2011) Yoon Woo Koh et al. ENDOCRINE-RELATED CANCER
- Mammalian Target of Rapamycin Pathway Activation Is Associated to RET Mutation Status in Medullary Thyroid Carcinoma
- (2011) Ida Rapa et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid Cancer
- (2011) Razelle Kurzrock et al. JOURNAL OF CLINICAL ONCOLOGY
- Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
- (2011) Samuel A. Wells et al. JOURNAL OF CLINICAL ONCOLOGY
- Everolimus for Advanced Pancreatic Neuroendocrine Tumors
- (2011) James C. Yao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vandetanib (100 mg) in Patients with Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer
- (2010) Bruce G. Robinson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Phase II Clinical Trial of Sorafenib in Metastatic Medullary Thyroid Cancer
- (2010) Elaine T. Lam et al. JOURNAL OF CLINICAL ONCOLOGY
- Pancreatic Endocrine Tumors: Expression Profiling Evidences a Role for AKT-mTOR Pathway
- (2009) Edoardo Missiaglia et al. JOURNAL OF CLINICAL ONCOLOGY
- The rapamycin-derivative RAD001 (everolimus) inhibits cell viability and interacts with the Akt–mTOR–p70S6K pathway in human medullary thyroid carcinoma cells
- (2009) Simona Grozinsky-Glasberg et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Dysregulated RET Signaling in Thyroid Cancer
- (2008) Maria Domenica Castellone et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- BRAFV600EMutation Is Associated with Preferential Sensitivity to Mitogen-Activated Protein Kinase Kinase Inhibition in Thyroid Cancer Cell Lines
- (2008) Rebecca Leboeuf et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Deoxyribonucleic Acid Profiling Analysis of 40 Human Thyroid Cancer Cell Lines Reveals Cross-Contamination Resulting in Cell Line Redundancy and Misidentification
- (2008) Rebecca E. Schweppe et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now